Summit Trail Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.6M Sell
41,515
-228
-0.5% -$21.8K 0.05% 240
2025
Q4
$4.04M Sell
41,743
-5,068
-11% -$492K 0.07% 164
2025
Q3
$4.49M Buy
46,811
+12,039
+35% +$1.11M 0.06% 161
2025
Q2
$3.06M Buy
34,772
+12,749
+58% +$1.08M 0.05% 182
2025
Q1
$1.99M Buy
22,023
+4,129
+23% +$369K 0.07% 96
2024
Q4
$1.44M Buy
17,894
+3,497
+24% +$303K 0.05% 106
2024
Q3
$1.31M Sell
14,397
-415
-3% -$34.9K 0.03% 220
2024
Q2
$1.18M Buy
14,812
+169
+1% +$13.9K 0.03% 214
2024
Q1
$1.29M Buy
14,643
+3,451
+31% +$295K 0.03% 178
2023
Q4
$930K Sell
11,192
-615
-5% -$46.9K 0.03% 190
2023
Q3
$933K Sell
11,807
-1,142
-9% -$95.6K 0.03% 174
2023
Q2
$1.15M Buy
12,949
+4,413
+52% +$380K 0.04% 150
2023
Q1
$694K Buy
8,536
+2,049
+32% +$167K 0.03% 176
2022
Q4
$508K Buy
6,487
+255
+4% +$20.7K 0.02% 183
2022
Q3
$507K Sell
6,232
-130
-2% -$11.7K 0.03% 177
2022
Q2
$575K Buy
6,362
+1,652
+35% +$167K 0.04% 167
2022
Q1
$525K Buy
+4,710
New +$498K 0.04% 162
2019
Q1
Sell
-2,741
Closed -$250K 119
2018
Q4
$250K Sell
2,741
-6,205
-69% -$580K 0.09% 89
2018
Q3
$884K Buy
8,946
+3,345
+60% +$309K 0.2% 66
2018
Q2
$480K Sell
5,601
-9,759
-64% -$815K 0.17% 73
2018
Q1
$819K Buy
15,360
+2,586
+20% +$213K 0.14% 156
2017
Q4
$1.08M Buy
+12,774
New +$1.02M 0.14% 147

Other funds holding MDT

Summit Trail Advisors's MDT Position: Q1 2026 in Review

Summit Trail Advisors reduced its Medtronic (MDT) stake by 0.55% in Q1 2026, selling an estimated $21.8K and leaving 41,515 shares worth $3.6M. The position accounts for 0.05% of the portfolio, ranked #240.

Summit Trail Advisors first reported a position in MDT in Q4 2017 and has held it in 22 quarters since. The position peaked at $4.49M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Summit Trail Advisors held 41,515 shares of Medtronic worth $3.6M as of Q1 2026.
  • Summit Trail Advisors sold 228 Medtronic shares in Q1 2026, an estimated $21.8K.
  • Medtronic made up 0.05% of Summit Trail Advisors's portfolio in Q1 2026, its #240 holding.
  • Summit Trail Advisors first reported a position in Medtronic in Q4 2017 and has held it in 22 quarters since.
  • Summit Trail Advisors's Medtronic position peaked at $4.49M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.